Quality of Life, Risk Factors and Mortality in Children with HIV/AIDS on 2nd Line Treatment, Slow Progressors and Late Presenters in Cambodian Orphanage
Abstract:Purpose of this paper was to review group of Cambodian children with AIDS -late presenters, coming to our programme with low immunologic status (CD4˂5%, and ˂100 CD4 cells) and opportunistic infections as well as children who started HAART too late according to the guidelines valid in 2003 -2005 (˂200 CD4 cells per cubic millimetre). Another aim of this study was to compare children with AIDS who are on 2 nd line HAART for risk factors, failure and outcome in comparison to children on 1 st line ARV. There was … Show more
“…Despite 10 children having a history of TB for the past 12 years, due to highly active antiretroviral therapy (HAART) all TB cases were cured after 6-0 months of combination of RIF+INH+PZA, Gene X-pert test was negative in all 31 children despite 4 having a recurrent history of TB within 6 months, all were receiving anti-TB therapy (3)(4).…”
Tuberculosis (TB) is one of the most frequent opportunistic infections in children with HIV in South-East Asia (SEA) together with candidiasis Original Article
“…Despite 10 children having a history of TB for the past 12 years, due to highly active antiretroviral therapy (HAART) all TB cases were cured after 6-0 months of combination of RIF+INH+PZA, Gene X-pert test was negative in all 31 children despite 4 having a recurrent history of TB within 6 months, all were receiving anti-TB therapy (3)(4).…”
Tuberculosis (TB) is one of the most frequent opportunistic infections in children with HIV in South-East Asia (SEA) together with candidiasis Original Article
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.